Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
9.11M
-
Shares change
-
+2.87M
-
Total reported value, excl. options
-
$63.6M
-
Value change
-
+$21.4M
-
Number of buys
-
36
-
Number of sells
-
-13
-
Price
-
$6.98
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2025
61 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q2 2025.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.11M shares
of 22M outstanding shares and own 41.35% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.7M shares), TORONTO DOMINION BANK (851K shares), Balyasny Asset Management L.P. (719K shares), VANGUARD GROUP INC (682K shares), Silvercrest Asset Management Group LLC (532K shares), MORGAN STANLEY (525K shares), Driehaus Capital Management LLC (481K shares), UBS Group AG (446K shares), WEXFORD CAPITAL LP (416K shares), and KENNEDY CAPITAL MANAGEMENT LLC (311K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.